HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

C&D Targets Innovation From Revenue Growth On Consumer Health Price Hikes

Executive Summary

CEO says higher revenues on consumer health product sales partly due to higher prices should go to innovation rather than advertising. During Q2 earnings briefing, analysts suggest competitors will boost promotions and hamper C&D’s 4% organic growth outlook for 2019.

You may also be interested in...



P&G’s Gamble To Hike Prices Pays Off With 4% Net Sales Growth In Q4

For the final quarter of its FY19, P&G reports 4% net sales growth to $17.1bn. Pricing and organic volume each contributed 3 percentage points to organic sales growth in the firm's strongest quarter since before the US financial crisis in 2008.

Church & Dwight Spreads Specialty Play, Pays Up To $900M For Hair Removal Line

Church & Dwight purchases Flawless Finishing Touch hair removal device line for $475m from IdeaVillage Products with plan to expand distribution outside US. Firm's 12th acquisition of brand at or near top of a consumer product category, the five-device line also aligns with plan to double international business.

Church & Dwight Expects 3.5% Growth In 2019 On Line Extensions, Price Increases

Church & Dwight estimates 3.5% organic sales growth in 2019 on innovations including Orajel Toothache Strips as well as organic gummy vitamins and "world’s first flossing toothbrush.” Reporting weaker-than-expected Q$ earnings, it plans to raise prices on more product categories in 2019.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149058

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel